InvestorsHub Logo
Followers 1
Posts 1659
Boards Moderated 0
Alias Born 07/27/2016

Re: gi197845 post# 10029

Thursday, 06/08/2017 9:46:07 AM

Thursday, June 08, 2017 9:46:07 AM

Post# of 20617
Dilution is a major problem with this company and a major reason for decline in the stock price over the last 8 months.

If they don't get their FDA approval by end of year, why did they pay out another 12.5M shares to Novalere? Also, if they approval doesn't happen, what about the 12.5M shares? Is the company going to get them back?
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.